Stock A063160 CKD BIO CORP.
Add to a list
To use this feature you must be a member
Log inSign up

All News CKD Bio Corp.

Equities

A063160

KR7063160006

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-05-30 EDT 		5-day change 1st Jan Change
22,300 KRW -.--% Intraday chart for CKD Bio Corp. -2.41% -6.50%
2023 CKD Bio Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 CKD Bio Corp.(KOSE:A063160) dropped from S&P Global BMI Index CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Healis Therapeutics' asset CKDB-501A shares Phase III topline results for glabellar injections from CKD Bio in South Korea
AQ
CKD Bio Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
CKD Bio Corp.(KOSE:A063160) dropped from S&P Global BMI Index
CI
CKD Bio Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
CKD Bio Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
CKD Bio Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
CKD Bio Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
CKD Bio Corp. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
CKD Bio Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Exclusive: South Korea's GL Rapha to ship out 10 million Sputnik Light COVID-19 shots this month
RE
Boryung Pharmaceutical : S.Korea's GL Rapha to ship out 10 mln Sputnik Light COVID-19 shots this month
RE
CKD Bio Corp.(KOSE:A063160) added to S&P Global BMI Index
CI
Chong Kun Dang Holdings Corp. completed the acquisition of additional 35.67% stake in Ckd Bio Corporation for KRW 61.6 billion.
CI
Chong Kun Dang Holdings Corp. made an offer to acquire an additional 35.67% stake in Ckd Bio Corporation for KRW 55.9 billion.
CI
Korea Securities Finance Corporation acquired 4.11% stake in Ckd Bio Corporation.
CI
Ckd Bio Corporation Announces Earnings Results for the Full Year Ended December 31, 2012
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A063160 Stock
  4. News CKD Bio Corp.